Department of Population Science, American Cancer Society, Kennesaw, Georgia.
Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis, Minnesota.
JAMA Oncol. 2023 Jan 1;9(1):79-87. doi: 10.1001/jamaoncol.2022.5153.
The number of cancer survivors living in the US is projected to be 26.1 million by 2040. Cancer survivors may be at increased risk of bone fractures, but research is limited in several important ways.
To investigate the associations of cancer diagnoses, including time since diagnosis and stage at diagnosis, with risks of pelvic, radial, and vertebral fractures (separately and combined) among older cancer survivors and compared with fracture risk among older adults without a history of cancer. Secondarily, to examine differences in risk of fracture stratified by modifiable behaviors, treatment, and cancer type.
DESIGN, SETTING, AND PARTICIPANTS: This longitudinal cohort study used data from 92 431 older adults in the US Cancer Prevention Study II Nutrition Cohort linked with 1999 to 2017 Medicare claims. Data were analyzed from July 15, 2021, to May 3, 2022.
Cancer history, time since cancer diagnosis, and stage at cancer diagnosis.
Hazard ratios (HRs) and 95% CIs for the risk of pelvic, radial, vertebral, and total frailty-related fractures were estimated using multivariate Cox proportional hazards regression. Stratification was used for secondary aims.
Among 92 431 participants (mean [SD] age, was 69.4 [6.0] years, 51 820 [56%] women, and 90 458 [97.9%] White], 12 943 participants experienced a frailty-related bone fracture. Compared with participants without a history of cancer, cancer survivors who were diagnosed 1 to less than 5 years earlier with advanced stage cancer had higher risk of fracture (HR, 2.12; 95% CI, 1.75-2.58). The higher fracture risk in cancer survivors with recent advanced stage diagnosis (vs no cancer) was driven largely by vertebral (HR, 2.46; 95% CI, 1.93-3.13) and pelvic (HR, 2.46; 95% CI, 1.84-3.29) fracture sites. Compared with cancer survivors who did not receive chemotherapy, survivors who received chemotherapy were more likely to have a fracture; this association was stronger within 5 years of diagnosis (HR, 1.31; 95% CI, 1.09-1.57) than 5 or more years after diagnosis (HR, 1.22; 95% CI, 0.99-1.51). Although the HR for risk of fracture was lower among physically active cancer survivors 5 or more years after diagnosis (HR, 0.76; 95% CI, 0.54-1.07), this result was not statistically significant, whereas current smoking was significantly associated with higher risk of fracture (HR, 2.27; 95% CI, 1.55-3.33).
Findings from this cohort study suggest that older adults with a history of cancer may benefit from clinical guidance on prevention of frailty-related fractures. If study findings are replicated, fracture prevention programs for survivors might include referrals for physical activity with cancer exercise professionals and smoking cessation programs.
预计到 2040 年,美国的癌症幸存者人数将达到 2610 万。癌症幸存者可能面临更高的骨折风险,但研究在几个重要方面受到限制。
调查癌症诊断(包括诊断后时间和诊断时的阶段)与老年癌症幸存者的骨盆、桡骨和椎体骨折(分别和合并)风险之间的关联,并与无癌症史的老年成年人的骨折风险进行比较。其次,检查按可改变的行为、治疗和癌症类型分层的骨折风险差异。
设计、设置和参与者:这项纵向队列研究使用了美国癌症预防研究 II 营养队列中 92431 名年龄较大的成年人的数据,并与 1999 年至 2017 年的医疗保险索赔数据相关联。数据分析于 2021 年 7 月 15 日至 2022 年 5 月 3 日进行。
癌症病史、癌症诊断后时间和癌症诊断时的阶段。
使用多变量 Cox 比例风险回归估计了骨盆、桡骨、椎体和总与虚弱相关的骨折风险的风险比(HR)和 95%置信区间。为了次要目的,进行了分层。
在 92431 名参与者(平均[标准差]年龄为 69.4[6.0]岁,51820 名[56%]为女性,90458 名[97.9%]为白人)中,有 12943 名参与者经历了与虚弱相关的骨折。与没有癌症史的参与者相比,1 至不到 5 年前被诊断为晚期癌症的癌症幸存者骨折风险更高(HR,2.12;95%CI,1.75-2.58)。最近被诊断为晚期癌症(而非无癌症)的癌症幸存者骨折风险较高,主要是由于椎体(HR,2.46;95%CI,1.93-3.13)和骨盆(HR,2.46;95%CI,1.84-3.29)骨折部位。与未接受化疗的癌症幸存者相比,接受化疗的幸存者更有可能发生骨折;这种关联在诊断后 5 年内更强(HR,1.31;95%CI,1.09-1.57),而诊断后 5 年以上则较弱(HR,1.22;95%CI,0.99-1.51)。尽管诊断后 5 年以上有活跃体力活动的癌症幸存者骨折风险较低(HR,0.76;95%CI,0.54-1.07),但这一结果并不具有统计学意义,而目前吸烟与更高的骨折风险显著相关(HR,2.27;95%CI,1.55-3.33)。
这项队列研究的结果表明,有癌症病史的老年成年人可能受益于预防与虚弱相关的骨折的临床指导。如果研究结果得到复制,幸存者的骨折预防计划可能包括向癌症运动专业人士咨询身体活动和戒烟计划。